Hervé M.
- Country
- France
- Department
- Dermatology
Research Overview
- Efficacy and Safety of Rituximab Versus Cyclophosphamide in Severe Mucous Membrane Pemphigoid: A Randomized, Double-Blind, Double-Dummy Controlled Trial
- Phase 3 Evaluation of Fianlimab and Cemiplimab Versus Pembrolizumab in Treatment-Naïve Unresectable Locally Advanced or Metastatic Melanoma
- Evaluation of Anifrolumab and Phototherapy Efficacy in Adults with Progressive Non-Segmental Vitiligo: A Randomized, Double-Blind, Phase II Study
Data & Insights
Has run more than one trial at 86 of 198 partner sites.
Specializations
Melanoma Research
The investigator specializes in advanced melanoma treatment, with particular focus on various stages of the disease including resectable stage 3-4 and unresectable locally advanced cases.
- Resectable Melanoma Management
- Metastatic Melanoma Treatment
- NRAS Mutant Cutaneous Melanoma
The research extends to innovative combination therapies and targeted treatments for different melanoma subtypes.
Autoimmune Skin Conditions
Focuses on treating severe autoimmune dermatological disorders, particularly pemphigoid and pemphigus conditions.
- Mucous Membrane Pemphigoid
- Pemphigus Vulgaris
- Pemphigus Foliaceus
Investigates personalized treatment approaches using biomarkers and innovative therapeutic combinations.
Pigmentation Disorders
Specializes in the treatment of progressive vitiligo with particular emphasis on combination therapeutic approaches.
- Non-segmental Vitiligo
- Phototherapy Combinations
- Repigmentation Therapies
Explores innovative treatment modalities for extensive vitiligo affecting significant body surface areas.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.